- Why Cryoport
- Who We Serve
- About Us
- News & Events
- Investor Relations
- Contact Us
President and Chief Executive Officer
Jerrell Shelton has more than 30 years of executive and corporate governance experience across several industries including information services, telecommunications, manufacturing and distribution. Previously, he was a visiting executive at IBM Research, where his team created and developed WebFountain, a project contributing significantly to IBM’s software strategy. He was also president and CEO of NDC Holdings, Continental Graphics Holdings, Thomson Business Information Group and Advantage Companies. Under his leadership, each of those companies achieved rapid revenue growth, improved profitability and increased shareholder value. Shelton holds a B.S.B.A. degree from the University of Tennessee and an MBA from Harvard Business School.
Chief Financial Officer, Treasurer and Corporate Secretary
Robert Stefanovich has more than 20 years of experience in financial management, including more than a decade as a senior-level financial executive in the health care and technology industries. Stefanovich has served as CFO of Novalar Pharmaceuticals, a venture-backed specialty pharmaceutical company. Previously, he served as the CFO of three publicly traded companies including Xcorporeal, a medical device company, Artemis International Solutions Corporation, a software company, and Aethlon Medical, a medical device company. Previously, he was vice president of administration at SAIC, a Fortune 500 company. Stefanovich also served as a member of the Software Advisory Group and as audit manager with Price Waterhouse LLP’s (now PricewaterhouseCoopers) technology practice in San Jose, Calif., and Frankfurt, Germany. He currently serves as a board member of Project InVision International, a leading provider of business performance improvement solutions. He received his master’s degree in business administration and engineering from the University of Darmstadt in Germany.
Chief Commercial Officer
Mark Sawicki brings 15 years of business development and sales management experience, having consistently delivered on corporate revenue and market share goals in the pharmaceutical and biotechnology industries. Sawicki was most recently the chief business officer at AAIPharma Services Corporation/Cambridge Major Laboratories Inc. Additionally, he has served in senior business development roles at CMC Biologics and Albany Molecular Research Inc. (AMRI), where he increased revenue at rates far outpacing industry standards. Sawicki holds a bachelor’s in biochemistry from the State University of New York at Buffalo and a Ph.D. in biochemistry from the State University of New York at Buffalo, School of Medicine and Biomedical Sciences. He also received graduate training at the Hauptman Woodard Medical Research Institute. Sawicki has authored a dozen scientific publications in drug discovery with a focus on oncology and immunology.
VICE PRESIDENT OF GLOBAL LOGISTICS
Robert Copeland brings 24 years of extensive international global operations & logistics experience. He has been involved at many levels of developing “Best in Class” cold chain supply networks and has an in-depth knowledge of customs & trade requirement. Robert has managed the biopharma and critical delivery distribution programs for multiple global companies in the temperature sensitive markets. Additionally, he implemented global infrastructures through multiple logistics IT systems integrations which managed communications for trade & customs document management, customer service, condition & GPS traceability, critical white glove delivery models and cold chain & dangerous goods distribution strategies. Moreover, structured implementation of standard compliance processes that supported cGMP, GDP, IATA, FAA, TSA, DOT, OSHA, ITAR, C-TPAT and ISO certifications. Robert holds a bachelor’s in business administration from Woodbury University, Burbank California and an Executive MBA from Pepperdine University Malibu California.
chief technology officer
Bret Bollinger has an extensive background in domestic and international manufacturing environments, along with experience in new product design and implementation. Prior to joining Cryoport, Bollinger was director of operations and engineering for Triangle Brass Manufacturing. Prior to that, he served as a business process consultant for Cardinal Health and served as operations and order fulfillment manager for Ingersoll-Rand's Falcon Lock Company. Bollinger holds a bachelor’s in mechanical engineering from Sacramento State University.
Vice President of Corporate Development
Thomas Heinzen brings over 23 years of executive experience in investment banking and equity trading to Cryoport. Prior to joining Cryoport in 2015, Heinzen was the head of trading at Protective Group Securities and later a senior vice president at Emergent Financial Group. He currently serves as chairman of the board for Spire Credit Union. Heinzen holds series 4, 7, 55, 63 and 65 securities licenses and has a bachelor’s degree in finance from the University of St. Thomas.
“Working with Cryoport was a truly remarkable difference compared to my experience with other shippers. With the previous shipping company I was working with, it took almost three months to establish a ‘deep frozen account’ and required numerous hoop-jumping shenanigans only to ultimately be informed that the company could not arrange a shipment to or from Israel, which they were informed from the start was our desired shipping source.
Our sales rep at this organization was as dumbfounded by our experience as we were. To his credit, after his company declined our business, he suggested I contact Cryoport. I have written thanking him for his suggestion and to let his ‘powers-that-be’ know how different my experiences were.”
"I want to thank everyone at Cryoport who was involved in the rapid recovery of the missing Cryoport shipper containing a patient’s tumor tissue. By promptly locating the shipper and recharging it while in transit, the patient was able to receive the vaccine manufactured from this tissue on time. We are so very appreciative of Cryoport’s customer service. Without the services that Cryoport provides, our clinical trials would not be available to patients."